OverviewSuggest Edit

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields. The Company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment.

TypePublic
Founded1944
HQAllen, TX, US
Websiteatrioncorp.com

Latest Updates

Employees (est.) (Jan 2020)616(+9%)
Revenue (FY, 2020)$147.6 M(-4%)
Share Price (Oct 2021)$717
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Atrion Office Locations

Atrion has an office in Allen
Allen, TX, US (HQ)
1 Allentown Pkwy
Show all (1)

Atrion Financials and Metrics

Atrion Revenue

Embed Graph
View revenue for all periods
Atrion's revenue was reported to be $147.59 m in FY, 2020
USD

Revenue (Q1, 2021)

39.2m

Gross profit (Q1, 2021)

16.3m

Gross profit margin (Q1, 2021), %

41.7%

Net income (Q1, 2021)

7.7m

EBIT (Q1, 2021)

8.9m

Market capitalization (22-Oct-2021)

1.3b

Closing stock price (22-Oct-2021)

717.0

Cash (31-Mar-2021)

29.4m
Atrion's current market capitalization is $1.3 b.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

145.7m143.5m146.6m152.4m155.1m147.6m

Revenue growth, %

4%(2%)2%

Cost of goods sold

74.8m75.9m75.8m80.7m84.4m81.4m

Gross profit

71.0m67.6m70.8m71.8m70.7m66.2m
Quarterly
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Revenue

36.2m36.1m37.8m38.5m36.2m37.9m39.4m38.8m39.3m41.6m40.1m38.9m43.6m38.0m39.2m

Cost of goods sold

18.7m18.9m20.2m19.9m18.5m19.5m20.5m19.6m21.3m22.9m21.5m21.0m23.7m20.5m22.8m

Gross profit

17.6m17.2m17.6m18.6m17.7m18.4m19.0m19.2m18.0m18.7m18.6m17.9m19.9m17.5m16.3m

Gross profit Margin, %

49%48%47%48%49%49%48%49%46%45%46%46%46%46%42%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

24.6m8.0m28.6m20.8m28.3m20.0m30.1m58.8m45.0m22.5m

Accounts Receivable

11.2m13.1m17.2m17.1m18.9m16.4m

Prepaid Expenses

2.3m3.1m2.5m3.9m

Inventories

24.6m23.8m26.3m28.0m29.8m29.0m29.4m33.6m42.1m50.3m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Cash

9.7m18.7m18.9m8.4m22.3m20.3m30.7m17.2m23.5m26.9m15.9m19.6m23.4m27.9m30.8m23.7m17.5m20.2m21.0m20.2m36.1m50.0m44.0m49.6m63.7m44.1m24.1m29.4m

Accounts Receivable

14.8m13.7m12.4m14.9m14.6m17.1m16.2m18.6m16.4m18.4m21.4m21.2m19.6m21.7m18.8m20.1m20.7m19.7m19.6m20.6m18.3m20.8m21.2m20.4m18.8m22.8m22.4m20.2m

Prepaid Expenses

2.8m1.5m865.0k2.2m1.5m2.3m2.6m1.8m2.9m2.7m1.4m3.2m2.4m

Inventories

21.1m23.4m25.6m24.9m24.5m25.2m26.5m26.3m27.2m28.4m26.7m27.5m29.2m30.5m31.2m30.1m30.4m30.0m29.9m29.9m32.5m32.2m32.8m34.6m38.3m41.3m45.8m49.5m
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

26.0m23.6m26.6m27.8m28.9m27.6m36.6m34.3m36.8m32.1m

Depreciation and Amortization

6.5m7.6m8.6m8.7m8.8m9.0m8.7m9.1m10.9m11.7m

Inventories

(7.2m)803.0k(2.5m)(1.8m)(1.7m)756.0k(339.0k)(4.2m)(8.5m)8.2m

Accounts Payable

2.0m(2.5m)(492.0k)(324.0k)213.0k725.0k1.3m2.1m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q1, 2021

Net Income

13.9m20.7m5.4m11.5m18.7m13.1m20.8m7.2m14.1m21.8m7.6m15.1m22.9m6.9m14.4m22.0m10.0m20.0m27.9m8.5m17.3m26.5m9.4m19.1m28.7m8.9m17.5m7.7m

Depreciation and Amortization

3.2m4.9m1.7m3.6m5.6m4.3m6.4m2.3m4.5m6.7m2.2m4.5m6.7m2.2m4.4m6.7m2.1m4.2m6.5m2.2m4.5m6.7m2.5m5.2m8.0m2.8m5.6m3.1m

Inventories

(3.7m)(6.0m)(1.1m)(317.0k)70.0k(1.4m)(2.7m)(59.0k)(942.0k)(2.1m)1.3m569.0k(1.2m)(697.0k)(1.4m)(285.0k)(1.3m)(950.0k)(909.0k)(553.0k)(3.1m)(2.8m)771.0k(1.0m)(4.7m)(841.0k)3.7m(779.0k)

Accounts Payable

2.7m3.4m(2.2m)(1.2m)(543.0k)2.9m(487.0k)(1.4m)265.0k773.0k(552.0k)1.7m(668.0k)862.0k2.2m316.0k542.0k277.0k(530.0k)518.0k(3.4m)
USDQ2, 2011

Financial Leverage

1.2 x
Show all financial metrics

Atrion Revenue Breakdown

Embed Graph

Atrion revenue breakdown by business segment: 44.4% from Fluid Delivery, 32.8% from Cardiovascular, 9.2% from Ophthalmology and 13.6% from Other

Atrion revenue breakdown by geographic segment: 63.5% from United States, 5.6% from Germany and 30.9% from Other countries less than 5% of revenues

Atrion Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Atrion Online and Social Media Presence

Embed Graph

Atrion News and Updates

Atrion Corporation Announces Election of New Director

ALLEN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced the election of Maria Sainz as a director, effective immediately.

Atrion Corporation Increases Quarterly Cash Dividend by 11%

ALLEN, Texas, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.75 per share to $1.95 per share. Specifically, the Board of Directors declared a quarterly dividend of $1.95 per share on its outstanding shares of Co…

Atrion Reports Results for Fourth Quarter and Full Year 2020

ALLEN, Texas, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced today that for the fourth quarter of 2020 revenues were $32.2 million compared to $34.5 million in the same period of 2019, net income was $7.4 million compared to $8.1 million in the prior year period, and…

Atrion Frequently Asked Questions

  • When was Atrion founded?

    Atrion was founded in 1944.

  • How many employees does Atrion have?

    Atrion has 616 employees.

  • What is Atrion revenue?

    Latest Atrion annual revenue is $147.6 m.

  • What is Atrion revenue per employee?

    Latest Atrion revenue per employee is $239.6 k.

  • Who are Atrion competitors?

    Competitors of Atrion include BSN Medical, Invacare and Varian Medical Systems.

  • Where is Atrion headquarters?

    Atrion headquarters is located at 1 Allentown Pkwy, Allen.

  • Where are Atrion offices?

    Atrion has an office in Allen.

  • How many offices does Atrion have?

    Atrion has 1 office.